Form 4: BIODESIX CEO Scott Hutton Reports Stock Transactions

BIODESIX President & CEO Scott Hutton reported the acquisition of shares from RSU vesting and a subsequent sale to cover taxes, following a recent reverse stock split.

Summary

• Scott Hutton, President & CEO and Director of BIODESIX INC, reported transactions involving the company's common stock.
• On November 10, 2025, Hutton acquired 611 shares of common stock through the vesting of Restricted Stock Units (RSUs).
• These numbers are adjusted to reflect a one-for-twenty reverse stock split effective September 15, 2025.
• Concurrently, 189 shares of common stock were sold at $7.62 per share to cover tax obligations arising from the RSU vesting.
• Following these transactions, Hutton directly beneficially owns 37,311 shares of common stock.
• The filing also notes the purchase of 448 shares under the Issuer's Employee Stock Purchase Plan on September 2, 2025, also adjusted for the reverse stock split.
• The RSUs vest in sixteen successive quarterly installments from February 8, 2022, contingent on continued service.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive due to the vesting of RSUs, indicating continued executive compensation and service. The subsequent sale for tax purposes is a routine and neutral event.

Positives

• Vesting of 611 Restricted Stock Units (RSUs) indicates continued compensation and alignment of executive interests with shareholders.
• The ongoing vesting schedule for RSUs, initiated February 8, 2022, suggests Scott Hutton's continued service and commitment to the company.

Negatives

• The sale of 189 shares of common stock, even for tax purposes, reduces Scott Hutton's direct beneficial ownership.

Future Outlook

The Restricted Stock Units (RSUs) are structured to vest in sixteen successive quarterly installments from February 8, 2022, indicating a long-term incentive plan contingent on Scott Hutton's continued service with the Issuer.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, common across all publicly traded industries, reflecting executive compensation and tax planning rather than specific industry trends.

Stakeholder Impact

• Shareholders: Minor impact as these are routine insider transactions related to executive compensation and tax management, unlikely to significantly alter market perception or share price.
• Employees: The Employee Stock Purchase Plan (ESPP) mentioned indicates a broader employee benefit program, potentially fostering employee ownership.

Next Steps

• Continued vesting of Restricted Stock Units in successive quarterly installments, subject to Scott Hutton's continued service.

Key Dates

Keywords

BIODESIX, BDSX, Scott Hutton, Insider Trading, Form 4, Restricted Stock Units, RSU Vesting, Stock Split, Employee Stock Purchase Plan